Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
CBC Pharma IPO is a fixed price issue of Rs 10.20 crores.
CBC Pharma IPO bidding started from January 31, 2020 and ended on February 6, 2020. The allotment for CBC Pharma IPO was finalized on Tuesday, February 11, 2020. The shares got listed on BSE SME on February 14, 2020.
CBC Pharma IPO price is ₹51 per share. The minimum lot size for an application is 2000 Shares. The minimum amount of investment required by retail investors is ₹102,000.
Beeline Broking Ltd is the book running lead manager of the CBC Pharma IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to CBC Pharma IPO DRHP for detailed information.
| IPO Date | January 31, 2020 to February 6, 2020 |
| Listing Date | February 14, 2020 |
| Face Value | ₹10 per share |
| Price | ₹51 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 2,000,000 shares (aggregating up to ₹10.20 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 5,545,056 |
| Share holding post issue | 7,545,056 |
| Market Maker portion | 200,000 shares |
CBC Pharma IPO offers 2,100,000 shares. 950,000 (45.24%) to NII, 950,000 (45.24%) to RII.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | - |
| Market Maker Shares Offered | 200,000 (9.52%) |
| Other Shares Offered | 950,000 (45.24%) |
| Retail Shares Offered | 950,000 (45.24%) |
| Total Shares Offered | 2,100,000 (100%) |
CBC Pharma IPO opens on January 31, 2020, and closes on February 6, 2020.
| IPO Open Date | Friday, January 31, 2020 |
| IPO Close Date | Thursday, February 6, 2020 |
| Basis of Allotment | Tuesday, February 11, 2020 |
| Initiation of Refunds | Thursday, February 13, 2020 |
| Credit of Shares to Demat | Thursday, February 13, 2020 |
| Listing Date | Friday, February 14, 2020 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 6, 2020 |
Investors can bid for a minimum of 2000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹102,000 |
| Retail (Max) | 1 | 2000 | ₹102,000 |
| Lot Size Calculator | |||
Mr. Hemant Chandravadan Bhagat and Mr. Pranav Hemant Bhagat are the promoters of the company.
| Share Holding Pre Issue | 96.72% |
| Share Holding Post Issue | 71.08% |
Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.
The company has own sales force and distribution network to work under the brand name and supply products to the Health care center and Hospital. Chandra Bhagat Pharma also deals in import, supply and indenting in Active Pharmaceuticals Ingredients (API) and the intermediate.
The company has FDA approval to get formulations manufactured from a contract manufacturer. It has a presence for formulations in some therapeutic categories such as Anesthesia, Cardiovascular, Anti-cancer (Oncology), Pediatrics, Nephrology, Antiviral, Anti-fungal, and Neurology. The warehouses/ storage houses of the company are on lease agreements at Bhiwandi- Thane, Maharashtra.
Chandra Bhagat Pharma also exports Pharmaceutical Formulations to other countries like DR Congo, Bolivia and Philippines.
Competitive Strengths
1. Customer centric and order driven business model
2. Relationships with MNCs
3. Wide product portfolio including API and pharmaceuticals
4. Contract manufacturing facility
5. Presence in India and international market
| Particulars | For the year/period ended (Rs in Lakhs) | ||||
|---|---|---|---|---|---|
| 30-July-19 | 31-Mar-19 | 31-Mar-18 | 31-Mar-17 | ||
| Total Assets | 8,594.26 | 8,285.52 | 5,805.76 | 5,589.60 | |
| Total Revenue | 3,344.50 | 10,671.83 | 9,773.41 | 9,028.11 | |
| Profit After Tax | 24.88 | 62.59 | 103.38 | 66.03 | |
The market capitalization of CBC Pharma IPO is Rs 38.48 Cr.
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 51 |
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
1. To Meet Incremental Working Capital Requirements;
2. Setting up Distribution and Warehousing Centre's;
3. General Corporate Purpose;
4. To meet Public Issue Expenses
[Dilip Davda] CBPL has shown inconsistency in bottom lines despite growing top lines. With the vaccine product launch plans up the sleeve, it is poised for bright prospects as claimed by the management. However, all these positive factors are discounted in the asking price. Hence only cash surplus, risk savvy investors may consider investment for long term at their own risk. Read detail review...
The CBC Pharma IPO is subscribed 1.65 times on February 6, 2020 6:45:03 PM. The public issue subscribed 1.44 times in the retail category, times in the QIB category, and 1.87 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 1.87 |
| Retail | 1.44 |
| Total | 1.65 |
| Listing Date | February 14, 2020 |
| BSE Script Code | 542934 |
| NSE Symbol | |
| ISIN | INE07QQ01016 |
| Final Issue Price | ₹51 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE SME |
|---|
| ₹51.00 |
| ₹51.70 |
| ₹51.00 |
| ₹52.10 |
| ₹51.75 |
Chandra Bhagat Pharma Ltd
323-F Bhagat Bhuvan,
Dr. Ambedkar Road,
Matunga (East) Mumbai- 400019
Phone: +91 22 2414 6154
Email: compliance@cbcpharma.net
Website: http://cbcpharma.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: cbpl.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
CBC Pharma IPO is a SME IPO of 2,000,000 equity shares of the face value of ₹10 aggregating up to ₹10.20 Crores. The issue is priced at ₹51 per share. The minimum order quantity is 2000 Shares.
The IPO opens on January 31, 2020, and closes on February 6, 2020.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
The CBC Pharma IPO opens on January 31, 2020 and closes on February 6, 2020.
CBC Pharma IPO lot size is 2000 Shares, and the minimum amount required is ₹102,000.
You can apply in CBC Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for CBC Pharma IPO will be done on Tuesday, February 11, 2020, and the allotted shares will be credited to your demat account by Thursday, February 13, 2020. Check the CBC Pharma IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
DRHP
IPO Guru (2200+ Posts, 1100+ Likes)
IPO Mentor (800+ Posts, 1000+ Likes)
Top Contributor (300+ Posts, 100+ Likes)
Sold 4 lot at 51.8
one lot holding, Now placed order at 51